Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine dose selection with thalidomide and dexamethasone in relapsed/refractory multiple myeloma
2010-021451-12Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bendamustine in multiple myeloma (MM) (2 arms), sponsored by University of Leeds. Primary endpoint: Joint primary endpoint. Started Oct 2010; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2010-021451-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021451-12.